217 related articles for article (PubMed ID: 12614975)
1. Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN).
Schiel R; Franke S; Appel T; Voigt U; Ross IS; Kientsch-Engel R; Stein G; Müller UA
J Diabetes Complications; 2003; 17(2):90-7. PubMed ID: 12614975
[TBL] [Abstract][Full Text] [Related]
2. Improvement of the quality of diabetes control and decrease in the concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus: results from a 10 year-prospective, population-based survey on the quality of diabetes care in Germany (JEVIN).
Schiel R; Franke S; Appel T; Voigt U; Ross IS; Kientsch-Engel R; Müller UA; Stein G
Eur J Med Res; 2004 Aug; 9(8):391-9. PubMed ID: 15337629
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Daimon M; Ono Y; Saito T; Yamaguchi H; Hirata A; Ohnuma H; Igarashi M; Eguchi H; Manaka H; Kato T
Diabetes Care; 1999 May; 22(5):877-8. PubMed ID: 10332715
[No Abstract] [Full Text] [Related]
5. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.
Kurt A; Andican G; Siva ZO; Andican A; Burcak G
J Physiol Biochem; 2016 Dec; 72(4):679-687. PubMed ID: 27448155
[TBL] [Abstract][Full Text] [Related]
6. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
[TBL] [Abstract][Full Text] [Related]
7. [Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].
Schiel R; Müller UA; Stein G
Med Klin (Munich); 2005 Aug; 100(8):453-61. PubMed ID: 16096726
[TBL] [Abstract][Full Text] [Related]
8. Pentosidine plasma levels and relation with metabolic control in diabetic patients.
Lapolla A; Reitano R; Baccarin L; Sartore G; Plebani M; Fedele D
Horm Metab Res; 2005 Apr; 37(4):252-6. PubMed ID: 15952087
[TBL] [Abstract][Full Text] [Related]
9. Structured diabetes therapy and education improves the outcome of patients with insulin treated diabetes mellitus. The 10 year follow-up of a prospective, population-based survey on the quality of diabetes care (the JEVIN Trial).
Schiel R; Voigt U; Ross IS; Braun A; Rillig A; Hunger-Dathe W; Stein G; Müller UA
Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):18-27. PubMed ID: 16450312
[TBL] [Abstract][Full Text] [Related]
10. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
11. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Hirata K; Kubo K
Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
[TBL] [Abstract][Full Text] [Related]
12. [Structured treatment and teaching programs and an improvement in private health care lead to a better quality of diabetes care. JEVIN, a population-based trial 1989/90 up to 1999/2000].
Schiel R; Müller UA
Med Klin (Munich); 2003 Jun; 98(6):303-12. PubMed ID: 12811414
[TBL] [Abstract][Full Text] [Related]
13. The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
Barzilay JI; Jablonski KA; Fonseca V; Shoelson SE; Goldfine AB; Strauch C; Monnier VM;
Diabetes Care; 2014 Apr; 37(4):1083-91. PubMed ID: 24255104
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
Busch M; Franke S; Wolf G; Rohde RD; Stein G;
Nephron Clin Pract; 2008; 108(4):c291-7. PubMed ID: 18434751
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin and pioglitazone on serum pentosidine levels in type 2 diabetes mellitus.
Kanazawa I; Yamamoto M; Yamaguchi T; Sugimoto T
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):362-5. PubMed ID: 21472665
[TBL] [Abstract][Full Text] [Related]
16. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
[TBL] [Abstract][Full Text] [Related]
18. Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.
O'Grady KL; Khosla S; Farr JN; Bondar OP; Atkinson EJ; Achenbach SJ; Eckhardt BA; Thicke BS; Tweed AJ; Volkman TL; Drake MT; Hines JM; Singh RJ
J Appl Lab Med; 2020 May; 5(3):558-568. PubMed ID: 32445362
[TBL] [Abstract][Full Text] [Related]
19. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
20. Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
Sveen KA; Karimé B; Jørum E; Mellgren SI; Fagerland MW; Monnier VM; Dahl-Jørgensen K; Hanssen KF
Diabetes Care; 2013 Nov; 36(11):3712-7. PubMed ID: 24026557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
